Sarah Snykers

Sarah Snykers has a strong background in the biotech industry, with a focus on cell therapy and research and development. Sarah most recently served as the Head of Operations at Legend Biotech, a position they have held since November 2021. Prior to this, Sarah worked at Celyad Oncology for six years, where they held various roles including Cell Therapy Manufacturing Unit Director, QC Manager, and External R&D Manager. At Celyad, Sarah was responsible for strategic and operational management, quality control, validation, and tech transfer of processes. Sarah also had budget and resource control responsibilities. Before Celyad Oncology, they worked at Promethera Biosciences as a Senior R&D/QC Manager and a Research Manager, overseeing various research projects and developing analytical methods. Sarah began their career as a Postdoctoral Researcher at Vrije Universiteit Brussel, specializing in pharmaceutical sciences and the hepatic potency of progenitor cells. Sarah holds a Ph.D. in Pharmaceutical Sciences from the same university.

Sarah Snykers completed their Master's degree in Pharmaceutical Sciences from Vrije Universiteit Brussel from 1997 to 2002. Prior to that, they achieved a High Distinction in Latin-Mathematics from Onze-Lieve Vrouwlyceum in Genk, Belgium, between 1991 and 1997. Additionally, Sarah attended a lagere school, but the specific details about their time there are not provided.